catechin has been researched along with okadaic acid in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiki, H; Komori, A; Ohta, T; Okabe, S; Sueoka, E; Suganuma, M; Yatsunami, J | 1 |
Yoshizawa, S | 1 |
Fujiki, H; Imanishi, Y; Kimura, S; Kitano, K; Nam, KY | 1 |
Aida, M; Fujiki, H; Kim, SJ; Nomura, T; Ochiai, Y; Okabe, S; Park, K; Suganuma, M | 1 |
Fujiki, H; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
Fujiki, H; Fujimoto, N; Goto, Y; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
Fujiki, H; Sueoka, E; Suganuma, M | 1 |
4 review(s) available for catechin and okadaic acid
Article | Year |
---|---|
A new tumor promotion pathway and its inhibitors.
Topics: Anticarcinogenic Agents; Catechin; Cyclohexanols; Diterpenes; Ethers, Cyclic; Humans; Neoplasms; Okadaic Acid; Tumor Necrosis Factor-alpha | 1994 |
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Catechin; Chemoprevention; Cohort Studies; Drug Synergism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Intestinal Neoplasms; Japan; Lung Neoplasms; Male; Mice; Mice, Mutant Strains; Okadaic Acid; Oligonucleotide Array Sequence Analysis; Prospective Studies; Ribonucleoproteins; Sulindac; Tea; Tumor Cells, Cultured | 2001 |
A new function of green tea: prevention of lifestyle-related diseases.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Catechin; Cohort Studies; Cricetinae; Female; Gene Expression Regulation; Humans; Interleukin-6; Japan; Life Style; Lung; Male; Mice; Mice, Transgenic; Neoplasms, Experimental; NF-kappa B; Okadaic Acid; Phytotherapy; Primary Prevention; Prospective Studies; Pulmonary Fibrosis; Rats; Risk; Tea; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2001 |
Tumor promoters: from chemicals to inflammatory proteins.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Catechin; Gastrointestinal Neoplasms; Helicobacter Infections; Humans; Inflammation; Inflammation Mediators; Neoplasms, Experimental; Okadaic Acid; Organ Specificity; Skin Neoplasms | 2013 |
4 other study(ies) available for catechin and okadaic acid
Article | Year |
---|---|
[(-)-Epigallocatechin gallate, the main constituent of Japanese green tea, inhibits tumor promotion of okadaic acid].
Topics: Animals; Antineoplastic Agents; Binding Sites; Carcinogens; Catechin; Mice; Okadaic Acid; Skin Neoplasms; Tea | 1996 |
Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A.
Topics: Catechin; Circular Dichroism; Enzyme Inhibitors; Lipid Bilayers; Liposomes; Okadaic Acid; Phosphoprotein Phosphatases; Protein Kinase C; Protein Phosphatase 2; Spectrometry, Fluorescence; Tetradecanoylphorbol Acetate | 1997 |
Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Flavonoids; Gene Expression; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Okadaic Acid; Phenols; Phytotherapy; Polymers; Stomach Neoplasms; Tea; Transcription Factor AP-1; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Catechin; Flavonoids; Gene Expression Regulation; Humans; Interleukin-1; Interleukin-10; Lung; Mice; Mice, Transgenic; Okadaic Acid; Phenols; Plant Extracts; Polymers; Recombinant Fusion Proteins; Tea; Tumor Necrosis Factor-alpha | 2000 |